Find Expert Doctors on Mucormycosis857 top medical experts on Mucormycosis across 49 countries and 34 U.S. states, including 734 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Mucormycosis: Infection in humans and animals caused by any fungus in the order mucorales (e.g., rhizopus; mucor; cunninghamella; apophysomyces; absidia; saksenaea and rhizomucor) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Zygomycosis (1,123).
- Clinical Trials
: at least 18 including 9 Completed, 6 Recruiting - Synonyms: Mucorales Infection, Mucorales Infections, Mucormycoses
- Kontoyiannis, Dimitrios P Infectious Disease
b Department of Infectious Diseases, Infection Control and Employee Health , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.Relevant US NIH Grant Funding: $160,000 over the last 5 yearsDisclosed payments in 2021 from 13 biomedical companies, totalling $19,258.62, including $9,620 from Gilead Sciences, Inc.Subjects: Antifungal Agents; Mucorales; Rhizopus; Lung Diseases, Fungal; TriazolesCategories: Drug Therapy; Therapeutic Use; Pathogenicity; Diagnosis; Microbiology; Epidemiology - Spellberg, Brad Infectious Disease Los Angeles County and University of Southern California LAC+USC Medical Center, Los Angeles, CA, USA. Top HospitalRelevant US NIH Grant Funding: $1,448,848 over the last 5 yearsDisclosed payments in 2021 from 2 biomedical companies, totalling $2,325, including $1,950 from GlaxoSmithKline, LLC.Subjects: Rhizopus; Antifungal Agents; Aspergillosis; Benzoates; EchinocandinsCategories: Metabolism; Therapeutic Use; Drug Therapy; Administration & Dosage; Pathogenicity; Mortality
- Walsh, Thomas J Infectious Disease Departments of Medicine, Pediatrics, Microbiology & Immunology, Weill Cornell Medicine, and New York Presbyterian Hospital, New York City, NY, USA.Disclosed payments in 2021 from 3 biomedical companies, totalling $210.21, including $198.26 from Astellas Pharma Global DevelopmentSubjects: Mucorales; Antifungal Agents; Lung Diseases, Fungal; Rhizopus; Amphotericin BCategories: Diagnosis; Drug Therapy; Pathogenicity; Epidemiology; Microbiology; Therapeutic Use
- Chakrabarti, Arunaloke Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.Subjects: Mucorales; COVID-19; Antifungal Agents; Diabetes Complications; Gastrointestinal DiseasesCategories: Diagnosis; Complications; Epidemiology; Etiology; Isolation & Purification; Classification
- Roilides, Emmanuel Infectious Diseases Unit, 3rd Department of Paediatrics, Aristotle University School of Medicine, Hippokration General Hospital, Thessaloniki, Greece.Subjects: Mucorales; Antifungal Agents; Rhizopus; Arthritis; OsteomyelitisCategories: Diagnosis; Drug Therapy; Therapeutic Use; Epidemiology; Pathogenicity; Complications
- Steinbach, William J Pediatrics Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke Universitygrid.26009.3d Medical Center, Durham, North Carolina, USA.Relevant US NIH Grant Funding: $1,475,794 over the last 5 yearsDisclosed payments in 2021 from 2 biomedical companies, totalling $198.26, including $198.26 from Astellas Pharma Global DevelopmentSubjects: Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Fungal Proteins; MucorCategories: Chemistry; Diagnosis; Therapy; Metabolism; Microbiology
- Ibrahim, Ashraf S Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California at Los Angeles UCLA Medical Center, Torrance, CA, USA. .Relevant US NIH Grant Funding: $2,891,898 over the last 5 yearsSubjects: Rhizopus; Antifungal Agents; Mucorales; Triazoles; Host-Pathogen InteractionsCategories: Therapeutic Use; Metabolism; Drug Therapy; Pathogenicity; Microbiology; Drug Effects
- Skiada, Anna Department of Infectious Diseases, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.Subjects: Mucorales; Aspergillosis; Candidiasis, Invasive; Dermatomycoses; Hematologic NeoplasmsCategories: Therapy; Diagnosis; Epidemiology; Complications; Etiology; Pathogenicity
- Cornely, Oliver Andreas Department of Internal Medicine, Excellence Center for Medical Mycology ECMM, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.Subjects: Antifungal Agents; Triazoles; Mucorales; Invasive Fungal Infections; Amphotericin BCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Diagnosis; Economics; Complications
- Lanternier, Fanny Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants malades Hospital, AP-HP, IHU Imagine, Paris, France; Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Mycologie Moléculaire, UMR 2000, Paris, France.Subjects: Amphotericin B; Antifungal Agents; Mucorales; Rhizopus; AbsidiaCategories: Therapy; Therapeutic Use; Diagnosis; Drug Therapy; Microbiology; Methods
- Perfect, John R Infectious Disease Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. Top HospitalRelevant US NIH Grant Funding: $5,337,209 over the last 5 yearsSubjects: Antifungal Agents; Triazoles; Amphotericin B; Benzoates; COVID-19Categories: Drug Therapy; Therapeutic Use; Administration & Dosage; Etiology; Diagnosis; Mortality
- Pagano, Livio Hematology Section, Fondazione Policlinico Universitario Agostino Gemelli- IRCCS , Rome, Italy.Subjects: Aspergillosis; Hematologic Neoplasms; Antifungal Agents; Brain Ischemia; Candidiasis, InvasiveCategories: Diagnosis; Therapy; Complications; Etiology; Administration & Dosage; Drug Therapy
- Lortholary, Olivier Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants malades Hospital, AP-HP, IHU Imagine, Paris, France; Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Mycologie Moléculaire, UMR 2000, Paris, France.Subjects: Antifungal Agents; Mucorales; Amphotericin B; Osteomyelitis; RhizopusCategories: Drug Therapy; Diagnosis; Therapeutic Use; Therapy; Epidemiology; Microbiology
- Groll, Andreas H InfectiousDisease Research Program, Department of Paediatric Hematology/Oncology and Center for Bone Marrow Transplantation, University Childrens Hospital Münster, Münster, Germany.Subjects: Aspergillosis; Candidiasis, Invasive; Mucorales; Hematologic Neoplasms; Hematopoietic Stem Cell TransplantationCategories: Therapy; Diagnosis; Etiology; Complications; Epidemiology; Adverse Effects
- Marty, Francisco M Infectious Disease Department of Medicine E.M.D., Cardiovascular Imaging Program, Departments of Medicine and Radiology S.C., S.P., A.A., M.F.D., R.B., Department of Pathology C.G., R.N.M., and Division of Infectious Disease, Department of Medicine R.M.M., Brigham and Womens Hospital, Boston, MA. Top HospitalDisclosed payments in 2021 from 2 biomedical companies, totalling $3,326, including $2,256 from Merck Sharp & Dohme CorporationSubjects: Antifungal Agents; Nitriles; Pyridines; Triazoles; AspergillosisCategories: Diagnostic Imaging; Therapeutic Use; Drug Therapy; Methods; Pharmacokinetics; Diagnosis
- Dannaoui, Eric Université Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.Subjects: Rhizopus; Antifungal Agents; Lung Diseases; Mucorales; AbsidiaCategories: Diagnosis; Drug Therapy; Therapeutic Use; Statistics & Numerical Data; Drug Effects; Epidemiology
- Chen, Sharon C A Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, and the Department of Infectious Diseases, Westmead Hospital, School of Medicine, University of Sydney, Sydney, NSW, Australia.Subjects: Antifungal Agents; Disease Management; Surgical Procedures, OperativeCategories: Diagnosis; Epidemiology; Therapy; Methods; Therapeutic Use
- Meis, Jacques F Department of Medical Microbiology and Infectious Diseases, Center of Expertise in Mycology, Radboud University Medical Center/Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.Subjects: Antifungal Agents; Mucorales; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; COVID-19Categories: Therapeutic Use; Diagnosis; Drug Therapy; Drug Effects; Complications; Epidemiology
- Muthu, Valliappan Departments of Radiodiagnosis and Imaging M.G., N.P., S.F., Pulmonary Medicine V.M., R.A., Medical Microbiology H.K., and Internal Medicine V.S., Post Graduate Institute of Medical Education & Research PGIMER, Chandigarh, India.Subjects: COVID-19; Antifungal Agents; Lung Diseases; Lung Diseases, Fungal; Zinc CompoundsCategories: Complications; Epidemiology; Diagnostic Imaging; Mortality; Standards; Therapeutic Use
- Lewis, Russell E Infectious Diseases Clinic, SantOrsola-Malpighi Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.Subjects: Antifungal Agents; Rhizopus; Lung Diseases, Fungal; Triazoles; MucoralesCategories: Drug Therapy; Drug Effects; Therapeutic Use; Pathogenicity; Immunology; Pharmacology
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.